Lv2
120 积分 2025-05-28 加入
ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib—A Case Report
1个月前
已完结
Lisaftoclax combined with ixazomib and dexamethasone after CAR-T for maintenance therapy in transplant-ineligible relapsed/refractory ultra-high-risk multiple myeloma: two case reports and literature review
1个月前
已完结
New Onset Persistent Hyperglycemia with Initiation of Brentuximab Treatment
1个月前
已关闭
Effectiveness of Sulbactam/Durlobactam in carbapenem-resistant Acinetobacter baumannii pulmonary infection complicated with carbapenem-resistant Enterobacterales and/or carbapenem-resistant Pseudomonas aeruginosa infection: A prospective, multicenter, cohort study
2个月前
已完结
Phase Ib of repotrectinib plus osimertinib in patients with EGFR–mutated advanced non–small cell lung cancer
3个月前
已关闭
Mo1239 COMPARATIVE SAFETY AND EFFICACY OF SUNITINIB, REPRETINIB, AND MASATINIB IN ADVANCED GIST: A NETWORK META-ANALYSIS OF RANDOMIZED TRIALS
3个月前
已关闭
Adagrasib-induced photodistributed hyperpigmentation: Two case reports and pathogenetic hypothesis
3个月前
已关闭
Reviving β-lactams for Mycobacterium abscessus: the emerging role of durlobactam
4个月前
已关闭
Phase 1 Trial of BCL-2 Inhibitor Lisaftoclax (APG-2575) in Chinese Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Other Non-Hodgkin Lymphomas
4个月前
已完结
Successful Treatment of Intra‐Abdominal Carbapenem‐Resistant Acinetobacter baumannii Infection With Sulbactam–Durlobactam in a Child With Acute Liver Failure Following Auxiliary Liver Transplantation
4个月前
已完结
皖公网安备34019202002308
